$CVM New Study in the Scientific Journal "Cancer Cell" Supports CEL-SCI’s Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses
https://finance.yahoo.com/news/study-scientif...00894.html
#STOCKS #STOCKSTOBUY #INVESTORS #STOCKS #TRADER #CVM